Atara Biotherapeutics Inc (ATRA) Insider Trading
- $3,819,989.71
- $54,295,355.57
- March 4, 2024
- Isaac E Ciechanover
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 11, 2015 | CEO | 5,200 | $46.16 | Sell | $240,032.00 | |
| Aug. 31, 2015 | insider | 5,000 | $41.99 | Sell | $209,950.00 | |
| Aug. 28, 2015 | CEO | 5,200 | $39.25 | Sell | $204,100.00 | |
| Aug. 24, 2015 | Director | 17,622 | $42.34 | Sell | $746,115.48 | |
| Aug. 19, 2015 | Director | 5,875 | $48.18 | Sell | $283,057.50 | |
| Aug. 18, 2015 | COO | 7,711 | $49.49 | Sell | $381,617.39 | |
| Aug. 18, 2015 | Director | 5,764 | $49.38 | Sell | $284,626.32 | |
| Aug. 18, 2015 | CFO | 6,000 | $49.38 | Sell | $296,280.00 | |
| Aug. 17, 2015 | Insider | 7,829 | $46.19 | Sell | $361,621.51 | |
| Aug. 17, 2015 | COO | 8,778 | $50.00 | Sell | $438,900.00 | |
| July 17, 2015 | CEO | 5,200 | $60.71 | Sell | $315,692.00 | |
| July 15, 2015 | Insider | 2,500 | $62.94 | Sell | $157,350.00 | |
| July 1, 2015 | Insider | 2,500 | $51.68 | Sell | $129,200.00 | |
| July 1, 2015 | CEO | 5,200 | $50.42 | Sell | $262,184.00 | |
| June 18, 2015 | CEO | 5,200 | $54.72 | Sell | $284,544.00 | |
| June 15, 2015 | CFO | 10,000 | $50.00 | Sell | $500,000.00 | |
| June 15, 2015 | Insider | 7,500 | $46.42 | Sell | $348,150.00 | |
| June 5, 2015 | CEO | 6,400 | $42.91 | Sell | $274,624.00 | |
| June 1, 2015 | Insider | 2,500 | $41.47 | Sell | $103,675.00 | |
| May 29, 2015 | CFO | 10,000 | $40.00 | Sell | $400,000.00 | |
| May 22, 2015 | CEO | 4,000 | $37.56 | Sell | $150,240.00 | |
| April 23, 2015 | CEO | 5,200 | $61.36 | Sell | $319,072.00 | |
| March 10, 2015 | Director | 4,000 | $29.57 | Buy | $118,280.00 | |
| Feb. 18, 2015 | Director | 11,000 | $18.00 | Buy | $198,000.00 | |
| Oct. 21, 2014 | Major Shareholder | 248,159 | $11.00 | Buy | $2,729,749.00 |
Insiders are both buying and selling Atara Biotherapeutics Inc stock.
The insider traders at Atara Biotherapeutics Inc are: Isaac E Ciechanover, Joe Newell, Christopher Haqq, Carol Giltner Gallagher, John Mcgrath, Utpal Koppikar, Pascal Touchon, Gad Soffer, Jakob Dupont, Amar Murugan, Mitchall G Clark, Eric J Hyllengren, Eric Dobmeier, Joel S Marcus, Derrell Porter, Mitchall G. Clark, Kristin Yarema, Matthew K Fust, Anhco Nguyen, William K Heiden, Domain Partners Viii, L.P., Heather D Turner, and Isaac E. Ciechanover
The most active insider trader at Atara Biotherapeutics Inc is Isaac E Ciechanover with 102 trades.
Isaac E Ciechanover has sold the most Atara Biotherapeutics Inc stock with a total value of $26,010,505.70.
Domain Partners Viii, L.P. has bought the most Atara Biotherapeutics Inc stock with a total value of $5,459,498.00.
The most recent insider trade for Atara Biotherapeutics Inc was on March 4, 2024.
The single biggest insider buy for Atara Biotherapeutics Inc was from Domain Partners Viii, L.P. with a total value of $2,729,749.00 on Oct. 21, 2014.
The single biggest insider sell for Atara Biotherapeutics Inc was from Isaac E Ciechanover with a total value of $2,336,000.00 on July 10, 2018.